sglt2 inhibitors vs glp-1 Comparative effectiveness of inhibitors, receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records GLP1 Receptor Agonists vs SGLT2-I
Description
Older adults, sedentary patients, or individuals who lose weight very rapidly often do better with agents that produce more moderate weight loss, an area where emerging oral options may play an important role

RAMP1 and RAMP3 differentially control amylins effects on food intake, glucose and energy balance in male and female mice

Am J Cardiol 2014;114:384-8.ArticlePubMed 123

They change gastric emptying rate and transit time, which modifies the intestinal environment including local pH levels and nutrient availability

Filling the Energy Gap During Weight Loss Many people on GLP-1 medications say the same thing

Targeted leptin receptor blockade: role of ventral tegmental area and nucleus of the solitary tract leptin receptors in body weight homeostasis
